arrow
Back
H

Hedwig M. Blommestein

Erasmus School of Health Policy and Management

17H-index
118Paper Count
1.0KCitation Count
Published Papers 48
Publication Date
Impact of Reimbursement on the Utilisation of Gene Expression Profiles and Chemotherapy Decision-Making in Dutch Breast Cancer Patients: A Population-Based Study
err2026-06-04
err0
errOAAI
errJoyce Meijer; Nienke Hermanns; Rhodé Bijlsma; Hedwig M. Blommestein; Desiree H. J. G. van den Bongard; Thijs van Dalen; Paul J. van Diest; Caroline A. Drukker; Cristina Guerrero Paez; Aafke H. Honkoop; Agnes Jager; Linetta B. Koppert; Sabine C. Linn; Marissa C. van Maaren; Ester J. Siemerink; Laura J. van ’t; José H. Volders; Marie Jeanne Vrancken Peeters; Sabine Siesling
errShare
errSave
Post-radiotherapy health utility and symptom trends in patients with non-metastatic head and neck cancer
err2026-03-10
err0
errOAAI
errDiego Larrotta-Castillo; Yi Hsuan Chen; Luuk van der Hoek; Bram Ramaekers; Brenda Leeneman; Carin A. Uyl-De Groot; Johannes A. Langendijk; Hedwig M. Blommestein
errShare
errSave
Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trial
err2025-11-21
err0
PREAI
errNoor Wortelboer, MD; Seamus Kent, PhD; Hedwig M Blommestein, PhD; Annemiek van Ommen-Nijhof, MD, PhD; Vincent van der Noort, PhD; Esther van den Pol, PhD; Cristina Guerrero Páez, MSc; Aart Beeker, MD; Karin Beelen, MD, PhD; Lisanne C Hamming, MD; Joan B Heijns, MD; Aafke H Honkoop, MD, PhD; Paul C de Jong, MD, PhD; Quirine C van Rossum-Schornagel, MD; Christa van Schaik-van de Mheen, MD; Jolien Tol, MD, PhD; Cathrien S Tromp-van Driel, MD; Suzan Vrijaldenhoven, MD, PhD; A Elise van Leeuwen-Stok, PhD; Gabe S Sonke, MD, PhD; Agnes Jager, MD, PhD; Inge R Konings, MD, PhD
errShare
errSave
Adaptive designs in randomized clinical trials: reanalysis of the HOVON87/NMSG18 multiple myeloma trial
err2025-10-30
err0
errOAAI
errMaarten R. Seefat; Niek G. van der Maas; Kazem Nasserinejad; Bronno van der Holt; Anders Waage; Ulf-Henrik Mellqvist; Annette Juul Vangsted; Anna J.T. Smit; Febe Smits; Paula F. Ypma; Niels W.C.J. van de Donk; Hedwig M. Blommestein; Jan J. Cornelissen; David G.J. Cucchi; Sonja Zweegman; Jurjen Versluis
errShare
errSave
Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus second-line for advanced breast cancer: a cost-effectiveness analysis of the phase 3 SONIA trial
err2025-10-25
err0
errOAAI
errNoor Wortelboer; Seamus Kent; Inge R. Konings; Annemiek van Ommen-Nijhof; Vincent van der Noort; Esther van den Pol; Cristina Guerrero Páez; Marlies L. van Bekkum; Franchette W.P.J. van den Berkmortel; Helga J. Droogendijk; Danny Houtsma; Hendrika M. Oosterkamp; Annemieke van der Padt-Pruijsten; Ester J.M. Siemerink; Jolien Tol; Annette A. van Zweeden; A. Elise van Leeuwen-Stok; Gabe S. Sonke; Agnes Jager; Hedwig M. Blommestein
errShare
errSave
Cost-benefit analysis of advanced CBCT imaging: Incremental costs and savings
err2025-08-14
err0
errOAAI
errDiego A. Larrotta-Castillo; Hedwig M. Blommestein; Britt Kunnen; Joan J. Penninkhof; Agustinus J.A.J. van de Schoot; Mischa S. Hoogeman; Steven F. Petit
errShare
errSave
Author Correction: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer
errNature
IF48.5
err2025-07-22
err0
PREAI
errGabe S. Sonke; Annemiek van Ommen-Nijhof; Noor Wortelboer; Vincent van der Noort; Astrid C. P. Swinkels; Hedwig M. Blommestein; Cristina Guerrero Paez; Linda Mol; Aart Beeker; Karin Beelen; Lisanne C. Hamming; Joan B. Heijns; Aafke H. Honkoop; Paul C. de Jong; Quirine C. van Rossum-Schornagel; Christa van Schaik-van de Mheen; Jolien Tol; Cathrien S. Tromp-van Driel; Suzan Vrijaldenhoven; A. Elise van Leeuwen-Stok; Inge R. Konings; Agnes Jager
errShare
errSave
Comment on: Treatment-related toxicity in head and neck cancer patients treated with proton therapy is less common than with conventional radiotherapy
err2025-07-14
err0
errOAAI
errYi Hsuan Chen; Michiel Kroesen; Mischa Hoogeman; Matthijs Versteegh; Carin Uyl-de Groot; Hedwig M. Blommestein
errShare
errSave
Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic model
err2025-03-01
err0
PREAI
errBlommestein, Hedwig M.; de Groot, Saskia; Leeneman, Brenda; Uyl-de Groot, Carin A.; Haanen, John B. A. G.; Wouters, Michel W. J. M.; Aarts, Maureen J. B.; van den Berkmortel, Franchette W. P. J.; Blokx, Willeke A. M.; Boers-Sonderen, Marye J.; van den Eertwegh, Alfons J. M.; de Groot, Jan Willem B.; Hospers, Geke A. P.; Kapiteijn, Ellen; van Not, Olivier J.; Veldt, Astrid A. M. van der; Suijkerbuijk, Karijn P. M.; Franken, Margreet G.
errShare
errSave
Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma
err2025-02-22
err1
errOAAI
errde Groot, Saskia; Blommestein, Hedwig M.; Leeneman, Brenda; Uyl-de Groot, Carin A.; Haanen, John B. A. G.; Wouters, Michel W. J. M.; Aarts, Maureen J. B.; van den Berkmortel, Franchette W. P. J.; Blokx, Willeke A. M.; Boers-Sonderen, Marye J.; van den Eertwegh, Alfons J. M.; de Groot, Jan Willem B.; Hospers, Geke A. P.; Kapiteijn, Ellen; van Not, Olivier J.; van der Veldt, Astrid A. M.; Suijkerbuijk, Karijn P. M.; van Baal, Pieter H. M.
errShare
errSave
Cost-effectiveness of CDK4/6 inhibitors in first- vs second-line for advanced breast cancer (ABC) in the phase III SONIA trial (BOOG 2017-03)
err2024-09-01
err1
PREAI
errWortelboer, N.; Kent, S.; Konings, I. R.; Van Ommen-Nijhof, A.; van der Noort, V.; van den Pol, E.; Paez, C. Guerrero; van Bekkum, M.; Droogendijk, H. J.; Erdkamp, F.; Houtsma, D.; Oosterkamp, H. M.; van der Padt-Pruijsten, A.; Siemerink, E. J.; Tol, J.; van Zweeden, A. A.; van Leeuwen-Stok, A. E.; Sonke, G. S.; Jager, A.; Blommestein, H. M.
errShare
errSave
Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial
err2024-08-01
err0
errOAAI
errSeefat, M. R.; Stege, C. A. M.; Lissenberg-Witte, B. I.; Levin, M. D.; Timmers, G. J.; Hoogendoorn, M.; Ypma, P. F.; Klein, S. K.; Velders, G. A.; Westerman, M.; Strobbe, L.; Durdu-Rayman, N.; Davidis-van Schoonhoven, M. A.; van Kampen, R. J. W.; Dijk, A. C.; Koster, A.; Silbermann, M. H.; van der Spek, E.; Beeker, A.; Erjavec, Z.; de Graauw, N. C. H. P.; Leys, M. B. L.; Sonneveld, P.; van de Donk, N. W. C. J.; Nasserinejad, K.; Blommestein, H. M.; Cucchi, D. G. J.; Zweegman, S.
errShare
errSave
Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer
err2024-01-01
err4
errOAAI
errMortensen, H. R.; Populaire, P.; Hoffmann, L.; Moeller, D. S.; Appelt, A.; Nafteux, P.; Muijs, C. T.; Grau, C.; Hawkins, M. A.; Troost, E. G. C.; Defraene, G.; Canters, R.; Clarke, C. S.; Weber, D. C.; Korevaar, E. W.; Haustermans, K.; Nordsmark, M.; Gebski, Val; Achiam, M. P.; Markar, Sheraz R.; Radhakrishna, Ganesh; Berbee, Maaike; Scartoni, Daniele; Orlandi, Ester; Doyen, Jerome; Gregoire, Vincent; Crehange, Gilles; Langendijk, Johannes; Lorgelly, Paula; Blommestein, Hedwig M.; Byskov, Camilla S.; Ehmsen, Mai L.; Jensen, Maria Fuglsang; Freixas, Gloria Vilches; Buetoft, Rebecca
errShare
errSave
High Hospital-related Costs at the End-of-life in Patients With Multiple Myeloma: A Single-center Study
err2023-06-01
err2
errOAAI
errBennink, Christine; Westgeest, Hans; Schoonen, Daan; Boersen, Femke; Sonneveld, Pieter; Hazelzet, Jan; Blommestein, Hedwig; van der Klift, Marjolein
errShare
errSave
Changes in survival in de novo metastatic cancer in an era of new medicines
err2023-03-29
err19
errOAAI
errLuyendijk, Marianne; Visser, Otto; Blommestein, Hedwig M.; de Hingh, Ignace H. J. T.; Hoebers, Frank J. P.; Jager, Agnes; Sonke, Gabe S.; de Vries, Elisabeth G. E.; Uyl-de Groot, Carin A.; Siesling, Sabine
errShare
errSave
Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer in the Netherlands
err2023-02-16
err3
errOAAI
errLuyendijk, Marianne; Blommestein, Hedwig; Uyl-de Groot, Carin; Siesling, Sabine; Jager, Agnes
errShare
errSave
Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients? Needs?
err2023-02-01
err3
errOAAI
errJongbloed, Elisabeth M.; Blommestein, Hedwig M.; van Schoubroeck, Hannah M.; Martens, John W. M.; Wilting, Saskia M.; Uyl-de Groot, Carin A.; Jager, Agnes
errShare
errSave
High hospital-related burden of treatment for multiple myeloma patients: outcomes of a feasibility study using reimbursement data from electronic health records
err2022-12-01
err2
errOAAI
errBennink, Christine; van der Klift, Marjolein; Sonneveld, Pieter; Hazelzet, Jan A.; Blommestein, Hedwig M.
errShare
errSave